SBIO | ALPS Medical Breakthroughs ETF Overview

(Stock Exchange: AMEX)

Day's Range	37.59 - 38.19
52 Week Range	23.21 - 38.80
Beta	0.89
Implied Volatility	47.17%
IV Rank	0.93%
Day's Volume	4,849
Average Volume	6,400
Shares Outstanding	3,000,625
Inception Date	2014-12-31

Assets	106,179,750
Asset Class	Equity
Expense Ratio	0.50
P/E Ratio	N/A
EPS	N/A
Dividend Yield	0.19%
Dividend Per Share	0.07
Dividend ExDate	N/A
Dividend PayDate	N/A

The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the U.S. Food and Drug Administration clinical trials.

*Chart delayed

Watching at SBIO technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on SBIO Technicals page.